Accepting Early Access — Q2 2026
Continuous
Glucose
Live Reading
62
mg/dL↓ Low
Freedom.

A skin-surface sensor the size of a coin delivers real-time glucose data every 90 seconds — no needles, no calibration, no guesswork.

Scroll
  • FDA Cleared
  • ISO 15197
  • HIPAA Compliant
  • Dexcom Compatible
  • Apple Health
  • Medicare B
  • Anthem
  • UnitedHealthcare
  • Cigna
  • Aetna
  • Blue Cross
  • Tricare
  • FDA Cleared
  • ISO 15197
  • HIPAA Compliant
  • Dexcom Compatible
  • Apple Health
  • Medicare B
  • Anthem
  • UnitedHealthcare
  • Cigna
  • Aetna
  • Blue Cross
  • Tricare
Reading Speed
4.2s
Average reading delivery

Your blood sugar, every moment — not every morning.

Traditional glucometers give you a snapshot. Pulse gives you a film. The micro-sensor beneath the adhesive patch reads interstitial glucose through the skin and delivers a new data point every 90 seconds, so you see spikes forming before they peak.

Close-up of a wrist wearing a small circular glucose sensor patch while gardening with soil-covered gloved hands in soft morning light
4.2s
Average reading delivery
Sensor Technology
0.003mm
Needle-free micro-sensor depth

Zero penetration. Zero hesitation.

The Pulse sensor reads glucose through optical spectroscopy — light, not metal, passes through the dermis. No lancets. No insertion. No calibration fingersticks. For the 34% of Type 1 patients who cite needle anxiety as the reason they skip readings, this changes the calculation entirely.

A pregnant woman in a light linen shirt looking at her phone with a small sensor visible on her forearm, soft window light behind her
0.003mm
Needle-free micro-sensor depth
Sensor Longevity
14 days
Single sensor lifespan

Put it on Monday. Replace it two Fridays later.

One sensor. Two full weeks. No mid-shift swap, no reordering panic, no sensor failure at 3 AM. For long-haul drivers managing CDL requirements, that means a full route from Chicago to Los Angeles covered by a single patch — and a continuous A1C record your DOT medical examiner can actually use.

A truck driver gripping a steering wheel on an open highway, a small sensor visible on the inside of his wrist, golden hour light through windshield
14 days
Single sensor lifespan
Clinical Outcome
92%
Reduced hypoglycemic episodes — month one

Visibility is the intervention.

In our post-market study of 1,204 users, 92% reported a measurable reduction in low glucose events within the first 30 days. Not because Pulse delivers insulin — but because seeing the number drop in real time at 74 mg/dL gives you the 15 minutes you need to eat the crackers before the shaking starts.

A teenage girl checking her phone at a sleepover with friends in the background, a small round sensor patch visible on her upper arm, relaxed and smiling
92%
Reduced hypoglycemic episodes — month one
Clinical Evidence

Numbers that hold up
in a lab, not just marketing.

98.4%
Clinical Accuracy

MARD (Mean Absolute Relative Difference) vs. lab venous blood draw across 847 participants in the PULSE-1 trial.

PULSE-1 Clinical Trial, 2024
92%
Hypoglycemic Reduction

Users who reported a measurable reduction in hypoglycemic episodes within the first 30 days of continuous wear.

Post-Market Surveillance Study, n=1,204
96.1%
Sensor Accuracy Retention

Accuracy maintained through day 14 with no recalibration required, validated across ambient temperatures 15–40°C.

Wearability Validation Study, 2025
89%
CDL Compliance Rate

Commercial drivers using Pulse who maintained A1C within DOT-acceptable range over 6-month follow-up period.

Occupational Health Outcomes Report, 2025

Ready to see your numbers?

Check if your insurance covers Pulse — takes 90 seconds.

Check My Coverage